Your browser doesn't support javascript.
loading
Using mHealth to improve tuberculosis case identification and treatment initiation in South Africa: Results from a pilot study.
Maraba, Noriah; Hoffmann, Christopher J; Chihota, Violet N; Chang, Larry W; Ismail, Nazir; Candy, Sue; Madibogo, Edwin; Katzwinkel, Marc; Churchyard, Gavin J; McCarthy, Kerrigan.
Afiliação
  • Maraba N; The Aurum Institute, Johannesburg, South Africa.
  • Hoffmann CJ; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Chihota VN; The Aurum Institute, Johannesburg, South Africa.
  • Chang LW; John Hopkins University School of Medicine, Baltimore, MD, United States of America.
  • Ismail N; The Aurum Institute, Johannesburg, South Africa.
  • Candy S; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Madibogo E; John Hopkins University School of Medicine, Baltimore, MD, United States of America.
  • Katzwinkel M; National Institute of Communicable Disease, Johannesburg, South Africa.
  • Churchyard GJ; National Institute of Communicable Disease, Johannesburg, South Africa.
  • McCarthy K; Department of Health and Social Development, City of Johannesburg, Johannesburg, South Africa.
PLoS One ; 13(7): e0199687, 2018.
Article em En | MEDLINE | ID: mdl-29969486
ABSTRACT

BACKGROUND:

Tuberculosis (TB) incidence in South Africa is among the highest globally. Initial loss to follow-up (ILFU), defined as not starting on TB treatment within 28 days of testing positive, is undermining control efforts. We assessed the feasibility, acceptability, and potential of a mHealth application to reduce ILFU.

METHODS:

An mHealth application was developed to capture patients TB investigation data, provide results and monitor treatment initiation. This was implemented in two primary health clinics (PHC) in inner-city Johannesburg. Feasibility was assessed by comparing documentation of personal details, specimen results for same individuals during implementation period (paper register and Mhealth application). Effectiveness was assessed by comparing proportion of patients with results within 48 hours, and proportion started on treatment within 28 days of testing TB positive during pre- implementation (paper register) and implementation (mHealth application) periods. In-depth interviews with patients and providers were conducted to assess acceptability of application.

RESULTS:

Pre-implementation, 457 patients were recorded in paper registers [195 (42.7%) male, median age 34 years (interquartile range IQR (28-40), 45 (10.5%) sputum Xpert positive]. During implementation, 319 patients were recorded in paper register and the mHealth application [131 (41.1%) male, median age 32 years (IQR 27-38), 33 (10.3%) sputum Xpert positive]. The proportion with complete personal details [mHealth 95.0% versus paper register 94.0%, (p = 0.54)] and proportion with documented

results:

[mHealth 97.4% versus paper register 97.8%, (p = 0.79)] were not different in the two methods. The proportion of results available within 48 hours [mHealth 96.8% versus paper register 68.6%), (p <0.001)], and the proportion on treatment within 28 days [mHealth 28/33 (84.8%) versus paper register 30/44 (68.2%), (p = 0.08)] increased during implementation but was not statistically significant. In-depth interviews showed that providers easily integrated the mHealth application into routine TB investigation and patients positively received the delivery of results via text message. Time from sputum collection to TB treatment initiation decreased from 4 days (pre-implementation) to 3 days but was not statistically significant.

CONCLUSIONS:

We demonstrated that implementation of the mHealth application was feasible, acceptable to health care providers and patients, and has potential to reduce the time to TB treatment initiation and ILFU in PHC settings.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Telemedicina / Mycobacterium tuberculosis Tipo de estudo: Diagnostic_studies / Prognostic_studies / Qualitative_research Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: África do Sul

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Telemedicina / Mycobacterium tuberculosis Tipo de estudo: Diagnostic_studies / Prognostic_studies / Qualitative_research Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: África do Sul